Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population

[1]  H. Luan,et al.  Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis , 2012, Breast Cancer Research and Treatment.

[2]  Inmaculada de Juan Jiménez,et al.  Low penetrance alleles as risk modifiers in familial and sporadic breast cancer , 2012, Familial Cancer.

[3]  He-guang Huang,et al.  Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. , 2012, The Tohoku journal of experimental medicine.

[4]  Fan Chen,et al.  Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality , 2012, Immunogenetics.

[5]  I. Chirivella González,et al.  Low penetrance alleles as risk modifiers in familial and sporadic breast cancer , 2012, Familial cancer.

[6]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[7]  J. Wesche,et al.  Fibroblast growth factors and their receptors in cancer. , 2011, The Biochemical journal.

[8]  R. Wolff,et al.  Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States , 2011, Breast Cancer Research and Treatment.

[9]  Jie Yang,et al.  Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects , 2011, Breast Cancer Research and Treatment.

[10]  O. Díez,et al.  Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families , 2011, Breast Cancer Research and Treatment.

[11]  R. Millikan,et al.  FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. , 2010, Carcinogenesis.

[12]  T. Meitinger,et al.  Low‐risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients , 2010, International journal of cancer.

[13]  Yushui Ma,et al.  Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer , 2010, Breast Cancer Research and Treatment.

[14]  A. Howell,et al.  Breast cancer susceptibility variants alter risks in familial disease , 2009, Journal of Medical Genetics.

[15]  Giske Ursin,et al.  FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. , 2009, Human molecular genetics.

[16]  S. Chanock,et al.  Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status , 2008, Clinical Cancer Research.

[17]  Hongbing Shen,et al.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. , 2008, Carcinogenesis.

[18]  R. Wilkins.  Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.

[19]  Stephen B. Gruber,et al.  FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli Populations , 2008, Cancer Epidemiology Biomarkers & Prevention.

[20]  B. Ponder,et al.  Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer , 2008, PLoS biology.

[21]  P. Gregersen,et al.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 , 2008, Proceedings of the National Academy of Sciences.

[22]  Frank Dudbridge,et al.  Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data , 2008, Human Heredity.

[23]  J. Klijn,et al.  Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases , 2007, Breast Cancer Research.

[24]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[25]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[26]  Nazneen Rahman,et al.  The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.

[27]  P. Chomczyński,et al.  The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on , 2006, Nature Protocols.

[28]  S. Ampuero,et al.  BRCA1 and BRCA2 mutations in a South American population. , 2006, Cancer genetics and cytogenetics.

[29]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[30]  N. Hynes,et al.  Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins , 2004, Oncogene.

[31]  E. Jabs,et al.  Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations , 2002, Cytogenetic and Genome Research.

[32]  E. Ostrander,et al.  Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases , 2000, Cancer.

[33]  L. Ala‐Kokko,et al.  Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Bertucci,et al.  Expression of fgf and fgf receptor genes in human breast cancer , 1995, International journal of cancer.

[35]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[36]  C. Valenzuela,et al.  Socioeconomic assortative mating in Santiago, Chile: a demonstration using stochastic matrices of mother-child relationships applied to ABO blood groups. , 1977, Social biology.

[37]  R. Cruz-coke.  [Ethnic origin and evolution of the Chilean population]. , 1976, Revista medica de Chile.

[38]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.